Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07852962 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study to Assess Drug Levels, Immune Response, Safety and Tolerability of BMS-986446 in Healthy Chinese Participants.

Name: Study to Assess Drug Levels, Immune Response, Safety and Tolerability of BMS-986446 in Healthy Chinese Participants. — clinical trial record (NCT07852962)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorBristol-Myers Squibb

Started2027-02-10

View on ClinicalTrials.gov ↗

Bristol-Myers Squibb

311 trials monitored

See 15 trials at risk

The purpose of this study is to assess the drug levels, immune response, safety and tolerability of BMS-986446 in healthy Chinese participants.

Trial Details

NCT Number	NCT07852962
Lead Sponsor	Bristol-Myers Squibb
Conditions	Healthy Volunteers
Enrollment	10 participants
Start Date	2027-02-10
Primary Completion	2027-07-18 (estimated)
Study Completion	2027-07-18 (estimated)
Updated on ClinicalTrials.gov	2026-10-01